PPT-Data Source: Data source: Medicare 5% sample. Point prevalent Medicare enrollees alive
Author : amelia | Published Date : 2023-12-30
Figure 71 Sources of prescription drug coverage in Medicare enrollees by population 2014 2016 Annual Data Report Vol 1 CKD Ch 7 2 a The catastrophic coverage
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Data Source: Data source: Medicare 5% sa..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Data Source: Data source: Medicare 5% sample. Point prevalent Medicare enrollees alive: Transcript
Figure 71 Sources of prescription drug coverage in Medicare enrollees by population 2014 2016 Annual Data Report Vol 1 CKD Ch 7 2 a The catastrophic coverage amount is the greater of 5 of medication cost or the values shown in the chart above In 2014 beneficiaries were charged 255 for those generic or preferred multisource drugs with a retail price less than 51 and 5 for those with a retail price over 51 For brand name drugs beneficiaries paid 635 for those drugs with a retail price less than 127 and 5 for those with a retail price over 127 Table adapted from httpwwwq1medicarecomPartDThe2014MedicarePartDOutlookphp . 2017 . Annual Data Report. Volume 1: Chronic Kidney Disease. 2. vol 1 Figure 7.1 Sources of prescription drug coverage in Medicare enrollees, by population, 201. 5. Data source: Medicare 5% sample. Point prevalent Medicare enrollees alive on January 1, 2015. Abbreviations: CKD, chronic kidney disease; LIS, Medicare Low-income Subsidy; Part D, Medicare prescription drug coverage benefit.. Figure i.1 Prevalence of CKD by stage among NHANES participants, 1988-2012. Vol . 1, CKD, . Ch. . i. 2. Stages of CKD – KDOQI 2002 Definitions. Stage 1: eGFR ≥ 90 ml/min/1.73m. 2. and ACR ≥ 30 mg/g. valvular. heart disease.. Figure 4.1 Cardiovascular disease in patients with or without CKD, 2013 . Vol 1, CKD, . Ch. 4. 2. . Table 4.1 Prevalence of cardiovascular comorbidities & procedures (%), . valvular. heart disease.. Figure 4.1 Cardiovascular disease in patients with or without CKD, 2013 . Vol 1, CKD, . Ch. 4. 2. . Table 4.1 Prevalence of cardiovascular comorbidities & procedures (%), . 2016 Annual Data Report, Vol . 1, CKD, . Ch. . 3. 2. Data source: Medicare 5 percent sample. January 1, 2014 point prevalent patients aged 66 and older. . Adj. : age/sex/race. Ref: all patients, 2014. Abbreviation: CKD, chronic kidney disease.. Figure i.1 Prevalence of CKD by stage among NHANES participants, 1988-2012. Vol 1, CKD, Intro. 2. Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, 1999-2004 & 2007–2012 participants aged 20 & older. Note: Cardiovascular disease designation is based on self-report of any CVD condition (see CKD Analytical Methods chapter for detail); CKD is defined as eGFR <60 or ACR ≥30. Abbreviations: ACR, urine albumin/creatinine ratio; CKD, chronic kidney disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; SR CVD, self-reported cardiovascular disease. This graphic also appears as Figure 1.1.. Data Source: VHA Administrative data, USRDS ESRD Database, CMS Medicare Inpatient and Outpatient data. Statesand territories of the United States of America Figure 8.1 Distribution of Black incident ESRD veterans (%) among 85,505 incident ESRD veterans across states and territories of the United States, 10/1/2007-3/31/2014 11Medicare COVID19 Case A count of beneficiaries with a diagnosis of COVID19 on a claim or encounter record for We use the following International Classification of Diseases ICD Tenth Revision ICD10 d http://kff.org/other/state-indicator/total-population. /. . . Medicaid and Medicare Together . P. rovide . H. ealth . I. nsurance . C. overage for More than 3 in 10 Americans. NOTE: FY is fiscal year. . Nearly one in four Medicare beneficiaries had a Medigap policy as a supplemental source of coverage in 2010. Other . Public/Private Coverage only. 1%. 15%. Medigap only. 4%. Medigap + Employer. 2%. Medigap + . Adj. : age/sex/race/prior year hospitalization/comorbidities. Ref: 2012 patients. Abbreviations: CKD, chronic kidney disease.. vol 1 Figure 3.1 Unadjusted and adjusted all-cause mortality rates (per 1,000 patient years at risk) for Medicare patients aged 66 and older, by CKD status and year, . Adj. : age/sex/race. Ref: all patients, 2013. Abbreviation: CKD, chronic kidney disease.. Table 3.1 Unadjusted and adjusted all-cause mortality rates (per 1,000 patient years . at . risk) for Medicare patients aged 66 and older, by CKD status, 2013. 2016 Annual Data Report, Vol . 2, ESRD. , . Ch. . 12. 2. a. The . catastrophic coverage amount is the greater of 5% of medication cost or the values shown in the chart above. In 2014, beneficiaries were charged $2.55 for those generic or preferred multisource drugs with a retail price less than $51 and 5% for those with a retail price over $51. For brand name drugs, beneficiaries paid $6.35 for those drugs with a retail price less than $127 and 5% for those with a retail price over $127. Table adapted from http://www.q1medicare.com/PartD-The-2014-Medicare-Part-D-Outlook.php. valvular. heart disease; VTE/PE, venous thromboembolism and pulmonary embolism.. Figure . 4.1 Prevalence . of cardiovascular diseases in patients with or without CKD, 2014 . . 2016 Annual Data Report, Vol 1, CKD, .
Download Document
Here is the link to download the presentation.
"Data Source: Data source: Medicare 5% sample. Point prevalent Medicare enrollees alive"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents
